Author(s)

Yanzhu Li, Lili Han, Yanmei Ma, Xuemei Fang^*

Department of Head and Neck, Affiliated Cancer Hospital of Sun Yat-sen University, Guangzhou, China.

Objective: To evaluate the feasibility and safety of the non-placement of a drainage tube in transvestibular endoscopic thyroid papillary carcinoma surgery by applying the concept of rapid rehabilitation surgery. Methods: 106 patients with papillary thyroid carcinoma in the Department of Head and Neck of Affiliated Cancer Hospital of Sun Yat-sen University were retrospectively analyzed, and the observation group (n = 43) 1 who underwent endoscopic surgery without negative pressure drainage tube in the hospital from January 2019 to March 2023 were selected. The control group (n = 63) underwent the same operation at the same time and placed the negative pressure drainage tube. Postoperative hematoma, incision infection, subcutaneous effusion, and use of painkillers were compared between the two groups. Results: There were no statistically significant differences in operation time, intraoperative blood loss, postoperative hospital stay, and number of lymph node dissection between the two groups (P > 0.05). No postoperative hematoma or incision infection occurred between the two groups. There were no statistically significant differences in the incidence of subcutaneous effusion and the use rate of painkillers between the two groups (P > 0.05). Conclusion: No drainage tube in patients undergoing endoscopic thyroid surgery through oral vestibular approach will not increase the probability of complications such as postoperative hematoma, incision infection, subcutaneous effusion, and the use of painkillers, but can improve the comfort of patients in the concept of rapid rehabilitation.

Thyroid Papillary Carcinoma, Transoral Vestibular Approach, Thyroidectomy, Drainage, Enhanced Recovery after Surgery

Li, Y. , Han, L. , Ma, Y. and Fang, X. (2024) Study on the Feasibility and Safety of Transvestibular Approach Endoscopy without Drainage after Operation of Papillary Thyroid Carcinoma. Journal of Cancer Therapy, 15, 401-410. doi: 10.4236/jct.2024.1512036.